-
Express Scripts (nasdaq: EXPR - news - people ), a pharmacy-benefits manager, recently removed Lipitor from its formulary.
FORBES: Has Lipitor Reached Its Limit?
-
On the earnings front, clothing retailer Express (EXPR) missed earnings expectations and lowered its full year earnings outlook, sending shares lower today.
FORBES: Daily Wrap
-
In corporate news this week, retailer Express (EXPR) announced that its third quarter earnings would come in below expectations due to weak sales trends in September.
FORBES: Weekly Market Wrap